{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:01:14Z","timestamp":1785765674378,"version":"3.56.0"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202102070001"],"award-info":[{"award-number":["202102070001"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Guangdong Provincial Key Laboratory of Research on Emergency in TCM","doi-asserted-by":"publisher","award":["2023B1212060062"],"award-info":[{"award-number":["2023B1212060062"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371998"],"award-info":[{"award-number":["82371998"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402345"],"award-info":[{"award-number":["82402345"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572296"],"award-info":[{"award-number":["82572296"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical efficacy of [10B]borono-l-phenylalanine ([10B]BPA)-mediated Boron Neutron Capture Therapy (BNCT) relies heavily on accurate patient stratification using the companion diagnostic tracer 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA). However, widespread clinical deployment is currently hindered by the limited production capacity and low molar activity of traditional electrophilic synthesis. To address this unmet need, we established a fully automated, GMP-compliant radiosynthesis of [18F]FBPA using a spirocyclic iodonium ylide (SCIDY) precursor on a commercial module. This optimized protocol delivered clinical-grade [18F]FBPA with a decay-corrected radiochemical yield of 15.5% \u00b1 6.3% and a high molar activity of 75.9 \u00b1 20.0 GBq\/\u03bcmol. In vivo evaluation in subcutaneous xenografts showed high specificity for LAT1-positive tumors. Furthermore, in orthotopic C6 glioma and CAL27 tongue squamous cell carcinoma models, the tracer demonstrated effective blood-brain barrier penetration and good contrast, achieving Tumor-to-Normal (T\/N) ratios of \u223c 3.3. Translational pharmacokinetic studies in nonhuman primates revealed rapid renal clearance and low background accumulation in critical head-and-neck organs, with a favorable effective dose of 0.012 mSv\/MBq. This study presents a robust, clinical-ready strategy for producing high-molar-activity [18F]FBPA, bridging the gap between advanced radiochemistry and precise BNCT treatment planning.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00177","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:02:23Z","timestamp":1783692143000},"page":"4133-4143","source":"Crossref","is-referenced-by-count":0,"title":["Automated\nRadiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models\nand Nonhuman Primates"],"prefix":"10.1021","volume":"23","author":[{"given":"Weijian","family":"Ye","sequence":"first","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Hu","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Tan","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wei","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Wei","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Ran","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College Beijing , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2549-629X","authenticated-orcid":true,"given":"Kuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College Beijing , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-6315","authenticated-orcid":true,"given":"Steven H.","family":"Liang","sequence":"additional","affiliation":[{"name":"Emory University , , 1364 Clifton Rd , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3001-9605","authenticated-orcid":true,"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Institutes for Quantum Science and Technology , , ,","place":["Chiba, Japan, 263-8555"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-1991","authenticated-orcid":true,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]},{"name":"Jinan University , , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"1","key":"2026080309074851100_cit1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/neuonc\/noab108","article-title":"Reactor-based boron\nneutron capture therapy for 44 cases of recurrent and refractory high-grade\nmeningiomas with long-term follow-up","volume":"24","author":"Takai","year":"2022","journal-title":"Neuro-Oncology"},{"key":"2026080309074851100_cit2","doi-asserted-by":"publisher","first-page":"601820","DOI":"10.3389\/fonc.2021.601820","article-title":"Boron Neutron Capture Therapy: A\nReview of Clinical Applications","volume":"11","author":"Malouff","year":"2021","journal-title":"Frontiers in\nOncology"},{"issue":"9","key":"2026080309074851100_cit3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cac2.12089","article-title":"Boron neutron capture\ntherapy: Current status and future perspectives","volume":"40","author":"Dymova","year":"2020","journal-title":"Cancer Communications"},{"issue":"10","key":"2026080309074851100_cit4","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1021\/acs.molpharmaceut.3c00701","article-title":"The Dawn of a New Era: Tumor-Targeting Boron Agents\nfor Neutron Capture\nTherapy","volume":"20","author":"Luo","year":"2023","journal-title":"Mol. Pharmaceutics"},{"key":"2026080309074851100_cit5","doi-asserted-by":"publisher","first-page":"215795","DOI":"10.1016\/j.ccr.2024.215795","article-title":"Novel promising\nboron agents for boron neutron capture therapy: Current status and\noutlook on the future","volume":"511","author":"Xu","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"5","key":"2026080309074851100_cit6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/cancers16050869","article-title":"Safety of\nBoron Neutron Capture Therapy\nwith Borofalan(10B) and Its Efficacy on Recurrent Head\nand Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing\nSurveillance","volume":"16","author":"Sato","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"2026080309074851100_cit7","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1002\/onco.13805","article-title":"Designation Products:\nBoron Neutron\nCapture Therapy for Head and Neck Carcinoma","volume":"26","author":"Kanno","year":"2021","journal-title":"Oncologist"},{"key":"2026080309074851100_cit8","doi-asserted-by":"publisher","first-page":"rraf07011","DOI":"10.1093\/jrr\/rraf070","article-title":"18F-BPA as a surrogate tracer for BPA in BNCT: comparative analysis\nof transport mechanisms and biodistribution","volume":"67","author":"Li","year":"2026","journal-title":"Journal of Radiation Research"},{"issue":"1","key":"2026080309074851100_cit9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12885-016-2913-x","article-title":"Comparison\nof the pharmacokinetics between L-BPA and L-FBPA using the same administration\ndose and protocol: a validation study for the theranostic approach\nusing [18F]-L-FBPA positron emission tomography in boron\nneutron capture therapy","volume":"16","author":"Watanabe","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"2026080309074851100_cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-018-0295-y","article-title":"Clinical trials\nfor treating recurrent head and neck cancer with boron neutron capture\ntherapy using the Tsing-Hua Open Pool Reactor","volume":"38","author":"Wang","year":"2018","journal-title":"Cancer Communications"},{"issue":"9","key":"2026080309074851100_cit11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/hed.20418","article-title":"First clinical case\nof boron neutron capture therapy for head and neck malignancies using 18F-BPA PET","volume":"28","author":"Aihara","year":"2006","journal-title":"Head & Neck"},{"issue":"11","key":"2026080309074851100_cit12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7250","article-title":"Preliminary outcomes\nof boron neutron\ncapture therapy for head and neck cancers as a treatment covered by\npublic health insurance system in Japan: Real-world experiences over\na 2-year period","volume":"13","author":"Takeno","year":"2024","journal-title":"Cancer Medicine"},{"issue":"6","key":"2026080309074851100_cit13","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.21037\/qims-23-1769","article-title":"Prognostic\nassessment of 18F-boronophenylalanine positron emission\ntomography (BPA-PET) in salvage boron neutron capture therapy for\nmalignant brain tumors","volume":"14","author":"Lin","year":"2024","journal-title":"Quantitative Imaging\nin Medicine and Surgery"},{"issue":"1","key":"2026080309074851100_cit14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13550-014-0070-2","article-title":"FBPA PET in boron neutron capture therapy for cancer:\nprediction of 10B concentration in the tumor and normal\ntissue in a rat xenograft model","volume":"4","author":"Hanaoka","year":"2014","journal-title":"EJNMMI Research"},{"issue":"4","key":"2026080309074851100_cit15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/biology10040334","article-title":"Salvage Boron\nNeutron Capture Therapy\nfor Malignant Brain Tumor Patients in Compliance with Emergency and\nCompassionate Use: Evaluation of 34 Cases in Taiwan","volume":"10","author":"Chen","year":"2021","journal-title":"Biology"},{"issue":"8","key":"2026080309074851100_cit16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/cells10082135","article-title":"Development of an Imaging Technique for Boron Neutron\nCapture Therapy","volume":"10","author":"Fukumitsu","year":"2021","journal-title":"Cells"},{"issue":"5","key":"2026080309074851100_cit17","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.3390\/ijms24054978","article-title":"Advances in Boron\nNeutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma","volume":"24","author":"Lan","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"2026080309074851100_cit18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13139-021-00719-1","article-title":"Improved Stability\nand Practicality for Synthesis of 4-Borono-2-[18F]fluoro-l-phenylalanine\nby Combination of [18O]O2 Single-Use and [18F]CH3COOF Labeling Agents","volume":"56","author":"Naka","year":"2022","journal-title":"Nuclear Medicine and Molecular Imaging"},{"key":"2026080309074851100_cit19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.apradiso.2015.06.034","article-title":"Automated\nelectrophilic radiosynthesis of [18F]FBPA using a modified\nnucleophilic GE TRACERlab FXFDG","volume":"104","author":"Mairinger","year":"2015","journal-title":"Applied Radiation and Isotopes"},{"issue":"4","key":"2026080309074851100_cit20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0883-2889(91)90133-L","article-title":"Synthesis and radiation\ndosimetry of 4-borono-2-[18F]fluoro-d,l-phenylalanine:\nA target compound for PET and boron neutron capture therapy","volume":"42","author":"Ishiwata","year":"1991","journal-title":"International Journal of Radiation Applications and Instrumentation.\nPart A. Applied Radiation and Isotopes"},{"issue":"2","key":"2026080309074851100_cit21","first-page":"302","article-title":"Evaluation\nof 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a\nprobe for boron neutron capture therapy in a glioma-bearing rat model","volume":"45","author":"Wang","year":"2004","journal-title":"J. Nucl. Med."},{"issue":"8","key":"2026080309074851100_cit22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jlcr.600","article-title":"Synthesis of 4-dihydroxyboryl-2-[18F]fluorophenylalanine with relatively high-specific activity","volume":"45","author":"Va\u0308ha\u0308talo","year":"2002","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"issue":"7","key":"2026080309074851100_cit23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12149-018-1268-6","article-title":"Reliable radiosynthesis\nof 4-[10B]borono-2-[18F]fluoro-l-phenylalanine\nwith quality assurance for boron neutron capture therapy-oriented\ndiagnosis","volume":"32","author":"Ishiwata","year":"2018","journal-title":"Annals of Nuclear Medicine"},{"issue":"3","key":"2026080309074851100_cit24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0969-8051(95)02038-1","article-title":"Metals\nsuitable for fluorine gas target bodies: First use of aluminum for\nthe production of [18F]F2","volume":"23","author":"Bishop","year":"1996","journal-title":"Nuclear Medicine and Biology"},{"issue":"7","key":"2026080309074851100_cit25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0969-8051(97)00078-4","article-title":"Fluorine-18-labeled\nfluorine gas for synthesis of tracer molecules","volume":"24","author":"Bergman","year":"1997","journal-title":"Nuclear Medicine and Biology"},{"issue":"4","key":"2026080309074851100_cit26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/jlcr.3489","article-title":"Vacuum ultraviolet\nphoton-mediated production of [18F]F2","volume":"60","author":"Krzyczmonik","year":"2017","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"issue":"1","key":"2026080309074851100_cit27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 Radiochemistry, Labeling\nStrategies and Synthetic Routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjugate\nChem."},{"issue":"5","key":"2026080309074851100_cit28","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.7150\/thno.99490","article-title":"LAT1-specific PET radiotracers: Development and clinical\nexperiences of a new class of cancer-specific radiopharmaceuticals","volume":"15","author":"Achmad","year":"2025","journal-title":"Theranostics"},{"issue":"71","key":"2026080309074851100_cit29","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1039\/D1CC03369G","article-title":"Nucleophilic radiosynthesis\nof boron neutron capture therapy-oriented PET probe [18F]FBPA using aryldiboron precursors","volume":"57","author":"He","year":"2021","journal-title":"Chem.\nCommun."},{"key":"2026080309074851100_cit30","doi-asserted-by":"publisher","first-page":"108313","DOI":"10.1016\/j.nucmedbio.2022.108313","article-title":"Comparison of the\nsynthesis and biological properties of no-carrier-added and carrier-added\n4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)","volume":"116\u2013117","author":"Chang","year":"2023","journal-title":"Nuclear Medicine and Biology"},{"issue":"7","key":"2026080309074851100_cit31","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1039\/C6SC00197A","article-title":"Mechanistic\nstudies and radiofluorination\nof structurally diverse pharmaceuticals with spirocyclic iodonium(III)\nylides","volume":"7","author":"Rotstein","year":"2016","journal-title":"Chemical Science"},{"issue":"5","key":"2026080309074851100_cit32","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41596-019-0149-3","article-title":"Facile 18F labeling of\nnon-activated arenes via a spirocyclic iodonium(III)\nylide method and its application in the synthesis of the mGluR5 PET\nradiopharmaceutical [18F]FPEB","volume":"14","author":"Liang","year":"2019","journal-title":"Nat.\nProtoc."},{"issue":"3","key":"2026080309074851100_cit33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jlcr.3824","article-title":"A concisely\nautomated synthesis of TSPO radiotracer [18F]FDPA based\non spirocyclic iodonium ylide method and validation for human use","volume":"63","author":"Wang","year":"2020","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"issue":"4","key":"2026080309074851100_cit34","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.apsb.2021.11.014","article-title":"Discovery of a highly\nspecific 18F-labeled PET ligand for phosphodiesterase 10A\nenabled by novel spirocyclic iodonium ylide radiofluorination","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2026080309074851100_cit35","first-page":"2","article-title":"The 2007 Recommendations\nof the International Commission on Radiological Protection","volume":"37","author":"Valentin","year":"2007","journal-title":"ICRP Publication 103"},{"issue":"12","key":"2026080309074851100_cit36","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1021\/acs.jmedchem.7b00432","article-title":"A Facile Radiolabeling\nof [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary\nPET Imaging Studies in Preclinical Models of Neuroinflammation","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"supplement 1","key":"2026080309074851100_cit37","first-page":"1606","article-title":"Synthesis\nof 4-borono-2-18F-fluoro-phenylalanine using copper-mediated\nnucleophilic radiofluorination","volume":"60","author":"Yoshimoto","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"1","key":"2026080309074851100_cit38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00259-006-0154-y","article-title":"Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis\n2-related schwannoma and meningioma studied with PET","volume":"34","author":"Havu-Aure\u0301n","year":"2007","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"2026080309074851100_cit39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12149-019-01347-8","article-title":"4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented\ndiagnosis: overview of a quarter century of research","volume":"33","author":"Ishiwata","year":"2019","journal-title":"Annals of Nuclear Medicine"},{"issue":"9","key":"2026080309074851100_cit40","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1021\/acs.molpharmaceut.8b00602","article-title":"Molar Activity of Ga-68\nLabeled PSMA Inhibitor Conjugates Determines\nPET Imaging Results","volume":"15","author":"Wurzer","year":"2018","journal-title":"Mol. Pharmaceutics"},{"issue":"1","key":"2026080309074851100_cit41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s41181-024-00308-5","article-title":"Numerical simulation method for the\nassessment of the effect of molar activity on the pharmacokinetics\nof radioligands in small animals","volume":"9","author":"Kikuchi","year":"2024","journal-title":"EJNMMI Radiopharmacy\nand Chemistry"},{"issue":"1","key":"2026080309074851100_cit42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13550-021-00829-z","article-title":"The effects of molar activity on\n[18F]FDOPA uptake in patients with neuroendocrine tumors","volume":"11","author":"Stormezand","year":"2021","journal-title":"EJNMMI Research"},{"issue":"2","key":"2026080309074851100_cit43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00259-016-3487-1","article-title":"18F-FBPA as a tumor-specific probe of L-type amino acid transporter\n1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET","volume":"44","author":"Watabe","year":"2017","journal-title":"European Journal of Nuclear\nMedicine and Molecular Imaging"},{"issue":"supplement 2","key":"2026080309074851100_cit44","first-page":"1423","article-title":"The correlation\nbetween FDG and FBPA uptakes in malignant tumors by PET\/CT","volume":"54","author":"Hiroi","year":"2013","journal-title":"J. Nucl. Med."},{"key":"2026080309074851100_cit45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nucmedbio.2020.12.006","article-title":"Biodistribution and\nradiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine:\nA comparative PET\/CT study with L-isomer in healthy human volunteers","volume":"94\u201395","author":"Yang","year":"2021","journal-title":"Nuclear Medicine and Biology"},{"issue":"supplement 1","key":"2026080309074851100_cit46","first-page":"141","article-title":"Comparative study of\nL and D-isomers\nof F18-FBPA: whole body distribution in rats using PET","volume":"59","author":"Romanov","year":"2018","journal-title":"J. Nucl. Med."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00177","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/8\/4133\/65858147\/acs.molpharmaceut.6c00177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/8\/4133\/65858147\/acs.molpharmaceut.6c00177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:18:46Z","timestamp":1785763126000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/8\/4133\/5205590\/Automated-Radiosynthesis-of-High-Molar-Activity-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,10]]},"published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00177","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}